GlassScriptPhysician profile
Armando L Rojas
NPI 1902982788
$11,381.86
in general payments reported to CMS, 2019-2025
25 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $39.87 · 2021: $76.99 · 2022: $259 · 2023: $88.70 · 2024: $386 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,810.04 | 2019 | |
| Astellas Pharma US INC | $283.69 | 2022-2025 | Veozah |
| Abbvie INC. | $157.28 | 2019-2021 | |
| Ethicon US, LLC | $134.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.04 | 2019-2025 | |
| Amgen INC. | $111.88 | 2019-2024 | Evenity, Prolia |
| Sage Therapeutics, LLC | $79.26 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $79.18 | 2023-2025 | Slynd |
| Sumitomo Pharma America, INC. | $67.23 | 2024-2025 | Myfembree |
| Exact Sciences Corporation | $57.41 | 2024-2025 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $55.58 | 2019 | |
| Allergan, INC. | $46.97 | 2019-2020 | |
| Hologic Sales and Service, LLC | $43.42 | 2024 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Organon LLC | $43.11 | 2024-2025 | Nexplanon |
| Conmed Corporation | $42.22 | 2022-2024 | Visiclear |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $38.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $38.59 | 2025 | |
| Mayne Pharma Commercial LLC | $33.94 | 2025 | |
| Pfizer INC. | $31.47 | 2023-2024 | |
| Supernus Pharmaceuticals, INC. | $27.81 | 2025 | Qelbree |
| Lupin INC. | $27.01 | 2019 | |
| Agile Therapeutics, INC. | $18.14 | 2024 | Twirla |
| Optumhealth Care Solutions, LLC | $16.10 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Millicent US INC | $14.77 | 2024 | Intrarosa |
| Avion Pharmaceuticals | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.